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Abstract
Obesity places major demands on the protein folding capacity of the endoplasmic reticulum (ER), resulting in ER
stress, a condition that promotes hepatic insulin resistance and steatosis. Here we identify the transcription factor,
Kruppel-like factor 15 (KLF15), as an essential mediator of ER stress-induced insulin resistance in the liver. Mice with
a targeted deletion of KLF15 exhibit increased hepatic ER stress, inflammation, and JNK activation compared to WT
mice; however, KLF15-/- mice are protected against hepatic insulin resistance and fatty liver under high-fat feeding
conditions and in response to pharmacological induction of ER stress. The mammalian target of rapamycin complex
1 (mTORC1), a key regulator of cellular energy homeostasis, has been shown to cooperate with ER stress signaling
pathways to promote hepatic insulin resistance and lipid accumulation. We find that the uncoupling of ER stress and
insulin resistance in KLF15-/- liver is associated with the maintenance of a low energy state characterized by
decreased mTORC1 activity, increased AMPK phosphorylation and PGC-1α expression and activation of autophagy,
an intracellular degradation process that enhances hepatic insulin sensitivity. Furthermore, in primary hepatocytes,
KLF15 deficiency markedly inhibits activation of mTORC1 by amino acids and insulin, suggesting a mechanism by
which KLF15 controls mTORC1-mediated insulin resistance. This study establishes KLF15 as an important molecular
link between ER stress and insulin action.
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Introduction
A variety of stimuli, including changes in nutrient availability,
oxidative stress, pathogen infection and abnormal Ca2+
regulation, can result in endoplasmic reticulum (ER) stress,
characterized by the accumulation of misfolded proteins in the
ER lumen (reviewed in 1). In order to adapt to ER stress,
multiple signaling pathways are activated as part of the
unfolded protein response (UPR). To date, three main ER
transmembrane proteins have been identified that serve as ER
stress sensors and activators of the UPR: inositol-requiring
kinase 1α (IRE1α), activating transcription factor 6 (ATF6) and
double-stranded RNA-dependent protein kinase (PKR)-like ER
kinase (PERK). Under normal physiological conditions,
association of these proteins with the ER lumen chaperone, 78
kD glucose-regulated protein (GRP78), represses their activity.
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ER stress promotes the dissociation of GRP78, permitting UPR
signaling to occur [2], [3]. Once activated, IRE1α and ATF6
counteract ER stress primarily via the induction of genes
encoding proteins that facilitate protein folding or degradation
[4], [5], while PERK functions mainly to decrease protein
translation by phosphorylating the alpha subunit of eukaryotic
translation initiation factor 2 (eIF2α) [6].
ER stress plays a critical role in the development of hepatic
insulin resistance (reviewed in 7). Hotamisligil and colleagues
[8] were the first to show that ER stress is increased in both
dietary and genetic models of mouse obesity. They further
found that ER stress reduces the activity of the insulin signaling
pathway via hyperactivation of c-Jun N-terminal kinase (JNK).
Multiple mechanisms have been shown to underlie the
activation of JNK in response to ER stress, including the
recruitment of JNK by an IRE1α-TNF receptor-associated
factor 2 (TRAF2) complex [9], calcium release from the ER and
mitochondrial production of reactive oxygen species (ROS)
[10], [11]. Activated JNK can promote insulin resistance
through serine phosphorylation of insulin receptor substrate 1
(IRS-1) and also via the induction of proinflammatory cytokines
that feed back and further activate JNK [12]. ER stress also
induces nuclear factor kappa B (NFΚB) signaling, which, like
JNK signaling, can promote insulin resistance via the induction
of inflammatory genes [13].
Recent studies have revealed the importance of autophagy,
a lysosomal pathway-mediated degradation process, in the
regulation of ER stress-induced insulin resistance [14]. During
autophagy, cytoplasmic components ranging from protein
aggregates to whole organelles are sequestered into a double-
membrane vesicle that fuses with the lysosome, where vesicle
contents are degraded (reviewed in 15). ER stress has been
shown to activate autophagy [16], and like the UPR, autophagy
may help to restore ER homeostasis [17]. In genetic and diet-
induced obesity, autophagy is markedly downregulated in the
liver, leading to reduced hepatic insulin action and increased
ER stress, and restoration of autophagy increases insulin
sensitivity [14], [18]. Mammalian target of rapamycin complex 1
(mTORC1), a central regulator of protein synthesis and cell
growth, is a key inhibitor of autophagy in response to growth
factors and nutrients [19] and is aberrantly hyperactivated in
the obese state [20]. Thus, mTORC1-mediated inhibition of
autophagy may play a key role in promoting insulin resistance.
Our current findings identify KLF15 as a critical regulator of
ER stress and autophagy signaling as well as an effector of
insulin and nutrient-mediated activation of mTORC1. Kruppel-
like factor 15 (KLF15) is a zinc finger DNA-binding protein
belonging to the Kruppel-like family of transcription factors [21],
[22] and a key regulator of metabolic pathways that control
adipogenesis [23], gluconeogenesis [24], [25], circadian
nitrogen homeostasis [26] and exercise adaptation in skeletal
muscle [27]. We now show that KLF15 plays an essential role
in ER stress-mediated insulin resistance in the liver.
Results
Metabolic responses of KLF15-deficient mice to high-
fat feeding
To evaluate the metabolic effects of diet-induced obesity in
KLF15-/- mice, we placed 3-4 month-old male WT and KLF15-/-
mice on a high-fat diet (HFD; 60% kcal from fat) for 14 weeks.
As shown in Figure 1A, KLF15-/- mice gain significantly less
body weight and fat mass than WT controls after 13 weeks of
HFD. Metabolic cage analyses (Figure 1B) showed no
significant differences between standard chow-fed WT and
KLF15-/- mice in food intake, physical activity or energy
expenditure (VO2 consumption and VCO2 production). After 12
weeks of HFD, daily food intake is significantly increased in
KLF15-/- versus WT mice; however, physical activity level and
energy expenditure are also increased in these mice,
consistent with decreased whole-body fat mass compared to
WT controls.
To assess whole-body insulin sensitivity, intraperitoneal
glucose tolerance tests (GTT) were performed after 8 weeks of
high-fat feeding (Figure S1). KLF15-/- mice show markedly
increased glucose tolerance compared to WT mice as
indicated by significantly reduced area under the curve of
glucose clearance. Plasma insulin levels during the GTT
indicate that improved glucose clearance in KLF15-/- versus WT
controls is not due to increased insulin secretion. After 14
weeks of HFD, organ-specific insulin sensitivity was measured
using hyperinsulinemic-euglycemic clamp analysis on
conscious WT and KLF15-/- mice (Figure 1C). Immediately prior
to the clamp, plasma was collected from overnight-fasted mice
and assayed for insulin and glucose concentrations. Consistent
with their insulin-sensitive phenotype, KLF15-/- mice showed a
significant 3-fold decrease in basal insulin levels versus WT
controls. Basal glucose levels in KLF15-/- mice were also
significantly decreased compared to WT controls. During the
clamp, KLF15-/- mice were more insulin sensitive than WT
mice, requiring a greater than 30-fold increase in glucose
infusion rate to maintain euglycemia. Although basal hepatic
glucose production (HGP) was similar between groups, we
found a substantial and statistically significant decrease in HGP
under insulin clamp conditions in KLF15-/- mice versus WT
controls. A trend of increased whole body glucose turnover
(peripheral glucose uptake) was observed in KLF15-/- mice that
did not reach statistical significance. Thus, under high-fat
feeding conditions, KLF15-/- mice are more insulin sensitive
than WT controls, primarily as a result of decreased hepatic
glucose production. We cannot rule out the possibility that
different results may be achieved by changing the age at which
HFD is introduced or the duration of high-fat feeding; however,
our data indicate that in mature mice, long-term high-fat
feeding leads to significantly increased insulin resistance in WT
versus KLF15-/- liver.
The association of hepatic insulin resistance with increased
hepatic lipid content is well-documented, and the mechanisms
underlying this association are the focus of current
investigation (reviewed in 28). As shown in Figure 1D (left), WT
mice accumulate ~10-fold more hepatic lipid than KLF15-/- mice
after 14 weeks of high-fat feeding. Thus, KLF15-/- mice are
KLF15 and ER Stress
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Figure 1.  Metabolic responses to high-fat feeding in KLF15-deficient versus control mice.  Male mice were placed on a high-
fat diet (HFD; 60% kcal from fat) at 3-4 months of age. A. Body composition. Body weight (n=11-12) and whole-body fat mass
(n=5-6) in wild-type (WT) and KLF15-/- (KO) mice were measured immediately prior to (chow) and 13 weeks after the start of HFD.
Right panels indicate change in body weight and fat mass during 13 week HFD period. B. Metabolic cage analysis. Assessment of
food intake, physical activity, O2 consumption and CO2 production immediately prior to (chow) and 12 weeks after the start of HFD
(n=6). C. Hyperinsulinemic-euglycemic clamp study. Clamp procedure was performed after 14 weeks of HFD. Top (left to right):
basal plasma insulin levels after an overnight fast, basal plasma glucose levels after an overnight fast, glucose infusion rate during
the insulin clamp. Bottom (left to right): basal hepatic glucose production (HGP) after an overnight fast (prior to insulin stimulation),
hepatic glucose production during the insulin clamp, and insulin-stimulated whole-body glucose turnover (peripheral glucose uptake;
n=5; results are representative of two individual experiments). D. Hepatic lipid content and lipid-related gene expression in WT
versus KLF15-/- mice. After 14 weeks of HFD, liver tissue from clamped mice was collected and flash frozen. To assess hepatic
lipid content, a triglyceride assay was performed using a commercially available kit (left; n=5-7). To measure lipid-related gene
expression, total RNA was isolated from liver tissue, reverse transcribed and amplified by QPCR using primers against the genes
shown (right; n=3). Figure 1 statistical comparisons were made using Student’s t test for unpaired samples. Values = mean ± SEM;
*p<0.05; **p<0.01 compared to WT control.
doi: 10.1371/journal.pone.0077851.g001
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protected against HFD-induced hepatic steatosis. mRNA
expression of lipid-related genes in these tissues was
assessed using real-time quantitative PCR (QPCR) analysis
(Figure 1D, right). Consistent with decreased hepatic lipid
content, KLF15-/- liver exhibited reduced mRNA levels of fatty
acid transport protein (FATP), fatty acid synthase (FASN) and
Apolipoprotein A-IV (ApoA-IV), which are involved in fatty acid
uptake/synthesis and triglyceride secretion, respectively.
Increased hepatic expression of peroxisome proliferator-
activated receptor gamma coactivator-1 alpha (PGC-1α) and
carnitine palmitoyl transferase 1a (CPT 1a) in KLF15-/- versus
WT mice suggests that enhanced fatty acid oxidation (FAO)
may play a role in reducing hepatic lipid levels in KLF15-/- mice.
Additional evidence for increased hepatic FAO in these mice
comes from the observation of elevated fasting concentrations
of the ketone, β-hydroxybutyrate, in whole blood from HFD-fed
KLF15-/- versus WT mice (Figure S2). Thus, the absence of
KLF15 inhibits the accumulation of hepatic lipid in response to
high-fat feeding, potentially via a mechanism involving
increased fatty acid oxidation.
KLF15 regulates the ER stress response
Consistent with the clamp data, phosphorylation of the
serine/threonine kinase, AKT, is increased in livers isolated
from insulin-stimulated KLF15-/- versus WT mice after 8 weeks
of HFD; however, these mice also exhibit increased hepatic
expression and phosphorylation of UPR genes compared to
WT littermates, providing evidence for uncoupling of ER stress
and insulin resistance (Figure 2A). We also find that UPR factor
expression and activity is significantly increased in hepatocytes
isolated from KLF15-/- versus WT mice, suggesting a liver
autonomous effect of KLF15 on ER stress signaling (Figure
2B). To further investigate the regulation of the UPR by KLF15,
we introduced exogenous KLF15 into WT primary hepatocytes
via adenoviral infection and treated infected cells with vehicle
or with tunicamycin (Tm; an inhibitor of N-linked glycosylation)
to induce acute ER stress. As shown in Figure 2C,
overexpression of KLF15 suppresses both basal and Tm-
induced expression and phosphorylation (where applicable) of
the critical UPR regulators PERK, IRE1α, ATF6 (full-length)
and GRP78. The induction of the amino acid degrading
enzyme alanine aminotransferase (ALT1), a known target of
KLF15, is included as a positive control. We also assessed the
effect of acute ER stress on KLF15 expression. Figure 2D
shows that in an AML-12 hepatocyte cell line, KLF15 mRNA
levels increase several-fold in response to treatment with Tm or
another common inducer of ER stress, thapsigargin (Tg; a
Ca2+-ATPase inhibitor). X-box-binding protein 1 (XBP-1)
expression levels are included as a positive control. Thus, like
UPR factors, KLF15 may be induced with ER stress in order to
restore ER homeostasis.
Elevated UPR activity in KLF15-deficient mice suggests a
chronic increase in ER stress; however, it may simply be an
indication that KLF15 is an upstream regulator of the UPR. To
distinguish between these possibilities, we performed
ultrastructural examination of ER morphology in liver tissue
isolated from HFD-fed WT and KLF15-/- mice using
transmission electron microscopy. As shown in Figure 2E, the
rough ER appears markedly dilated in KLF15-/- compared with
WT hepatocytes, with a significant increase in average
diameter of the ER lumen. This indicates that the absence of
KLF15 causes ER stress, and that increased UPR signaling in
KLF15-/- liver occurs, at least in part, as a response to this
condition. At this time, it is unclear whether KLF15 may also
affect ER stress signaling as a direct transcriptional regulator of
UPR gene expression. For example, we find that
overexpression of KLF15 in WT hepatocytes significantly
reduces transcript levels of GRP78 and PERK; however,
preliminary chromatin immunoprecipitation analyses have not
yet identified definitive KLF15 binding sites in the proximal
promoter regions of these genes (data not shown).
Further support for liver-autonomous effects of KLF15 on ER
stress signaling comes from analysis of mice with a liver-
specific knockdown of KLF15 generated via tail vein injection of
adenoviral small hairpin RNA (shRNA). As shown in Figure 3A,
reduction of hepatic KLF15 expression in chow-fed mice
significantly increases GRP78 expression and PERK
phosphorylation compared to control mice (left panel). A similar
trend is seen in HFD-fed mice; however, induction of GRP78
expression in response to KLF15 knockdown does not reach
statistical significance (right panel). Furthermore, mice with a
liver-specific knockdown of KLF15 show increased whole-body
insulin sensitivity compared to WT controls under both chow
and high-fat feeding conditions (Figure 3B), supporting a liver-
autonomous role for KLF15 in the regulation of glucose
homeostasis. QPCR amplification of first-strand cDNA
templates from multiple tissue types isolated from chow-fed
control and KLF15 knockdown mice provides evidence for liver-
specific targeting of KLF15 (Figure 3C). Our data indicate that
uncoupling of ER stress and insulin resistance results from liver
autonomous effects of KLF15 deficiency and is independent of
dietary conditions.
KLF15 mediates ER stress-induced hepatic lipid
accumulation and insulin resistance
ER stress plays an important role in the development of fatty
liver. Under high-fat feeding conditions, protection against
hepatic steatosis in KLF15-/- mice is associated with increased
hepatic ER stress, suggesting that KLF15 may be required for
ER stress-induced hepatic lipid accumulation. To test this
hypothesis, chow-fed WT and KLF15-/- mice received an
intraperitoneal injection of vehicle or 3 mg/kg Tm and livers
were taken 24h post-injection. As shown in Figure 4A (left), in
response to Tm treatment, hepatic triglyceride content in WT
mice increases by ~30mg/g liver versus an ~10mg/g liver
increase in KLF15-/- mice. These results are supported by Oil
Red O staining of frozen liver sections from these mice (Figure
4A, right). Thus, compared to WT controls, KLF15-/- mice are
protected against ER stress-induced fatty liver. Protection
against both HFD and ER stress-induced hepatic steatosis is
likely to contribute to increased hepatic insulin sensitivity in
KLF15-/- mice.
Because KLF15-/- mice show indications of chronic ER stress
but remain insulin sensitive compared to WT littermates, we
hypothesized that KLF15 may mediate ER stress-induced
insulin resistance. To test this, we treated primary hepatocytes
KLF15 and ER Stress
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Figure 2.  Regulation of the unfolded protein response by KLF15.  A. UPR activity in WT versus KLF15-/- liver after high-fat
feeding. 2-month-old WT and KLF15-/- male mice received HFD (60% kcal from fat) for 8 weeks, then were fasted for 5h, i.p.
injected with 10mU/g insulin and sacrificed 10 minutes post-injection. Liver lysates were subjected to immunoblotting (n=3). B.
Western analysis of UPR activity in WT versus KLF15-/- primary hepatocytes. Hepatocytes were isolated from standard chow-
fed 4-month-old male WT and KLF15-/- mice. C. Effect of KLF15 overexpression on UPR activity. Western analysis of
hepatocytes isolated from chow-fed 4-month-old WT male mice infected with empty vector (EV) or KLF15-expressing adenovirus.
Cells were treated for 6h with vehicle (DMSO) or 5µg/ml tunicamycin (Tm) before harvest. D. Induction of KLF15 in response to
acute ER stress. AML-12 hepatocytes were treated for 7h hours with vehicle or 5µg/ml tunicamycin (Tm; top panel) or for 5h with
vehicle or 1µM thapsigargin (Tg; bottom panel). Total RNA was isolated from harvested cells, reverse transcribed and subjected to
QPCR. E. Ultrastructural examination of ER morphology. WT and KLF15-/- female mice (n=3) received HFD (60% kcal from fat)
for 4 weeks starting at age 3 months. Mice were fasted for 21h before sacrifice and liver tissue was removed and prepared for
transmission electron microscopy analysis as described in Materials and Methods. Left: Representative electron micrographs
(original magnification = 20,500x) of liver sections. Lower pictures show an enlarged portion of the field above. Scale bar = 0.5 μm.
Right: Quantitation of ER lumen diameter. Values = average lumen diameter/cell representative of 9 cells/group. In each cell, lumen
diameter measurements were taken along the length of each of 10 ER cisternae. For Figure 2B, C and D, two individual
experiments were performed in triplicate; each lane (in B, C) indicates a technical replicate. For Figure 2A, each lane represents
one mouse. Values = mean ± SEM; *p<0.05; **p<0.01 (Student’s t test for unpaired samples).
doi: 10.1371/journal.pone.0077851.g002
KLF15 and ER Stress
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Figure 3.  Uncoupling of ER stress and insulin resistance in mice with a liver-specific knockdown of KLF15.  A. Effect of
liver-specific knockdown of KLF15 on the hepatic UPR. C57BL/6 male mice received a tail vein injection of 1.5 x 1011 viral
particles of either shControl or shKLF15 adenovirus under chow feeding conditions at 13 weeks of age or after 5 weeks of high-fat
feeding at 14 weeks of age. Chow-fed mice (Day 4 post-injection) and HFD-fed mice (Day 6 post-injection) were fasted for 4h
followed by i.p. injection of 10mU/g insulin and were sacrificed 10 minutes post-insulin injection. Liver lysates were subjected to
Western analysis with the indicated antibodies. Each lane represents one mouse (n=3). Quantitation graphs are shown below blots.
B. Glucose tolerance tests. C57BL/6 male mice received a tail vein injection of 1.5 x 1011 viral particles of shControl or shKLF15
adenovirus under chow feeding conditions at 10 weeks of age or after 5 weeks of high-fat feeding at 14 weeks of age. Four days
after tail vein injection, mice were injected i.p. with 1g glucose/kg body weight after a 16h fast. Tail vein blood samples were
assessed for glucose concentration immediately before i.p. injection (Time 0) and at 15, 30, 60 and 120 minutes post-injection.
Blood glucose concentrations during the GTT and corresponding area under the curve calculations for glucose values are shown for
chow- and HFD-fed mice. n=6-7 mice/group for both studies. C. Liver specificity of KLF15 knockdown. Quantitative PCR
evaluation of KLF15 mRNA levels in liver, quadriceps muscle, white adipose and heart tissues isolated from chow-fed mice that
were tail vein-injected with shControl (C) or shKLF15 (K) adenovirus. n=3. Figure 3 statistical comparisons were made using
Student’s t test for unpaired samples or, for glucose values during GTT, analysis of variance for repeated measures with a
Bonferroni post hoc test. Values = mean ± SEM; *p<0.05; **p<0.01 compared to WT control.
doi: 10.1371/journal.pone.0077851.g003
KLF15 and ER Stress
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isolated from chow-fed WT and KLF15-/- mice with vehicle,
insulin only, or insulin preceded by a 20h treatment with 2µg/ml
Tm (Figure 4B). We found that Tm pretreatment significantly
decreased insulin-stimulated phosphorylation of AKT in WT,
but not in KLF15-/- hepatocytes. These results indicate that,
under acute ER stress conditions, the absence of KLF15
enhances insulin signaling pathway activity.
Figure 4.  Protection against ER stress-induced hepatic lipid accumulation and insulin resistance KLF15-/- liver.  A. Hepatic
lipid accumulation in response to tunicamycin treatment in WT versus KLF15-/- mice. 5-month-old male WT and KLF15-/- mice
on a standard chow diet with free access to food were i.p. injected with vehicle or 3mg/kg tunicamycin (Tm). 24h post injection, mice
were sacrificed and liver tissue removed and flash frozen. Liver tissues were subjected to triglyceride assay with a commercially
available kit (left; n=7). Oil Red O staining (right) was performed on frozen liver sections for detection of neutral lipid. Representative
samples are pictured. B. Effect of acute ER stress on AKT activity in WT versus KLF15-/- primary hepatocytes. Hepatocytes
were isolated from standard chow-fed 2.5-month-old male WT and KLF15-/- mice and treated for 10 minutes with vehicle, 100nM
insulin or 100nM insulin preceded by 20h treatment with 2µg/ml tunicamycin (Tm). Lysates were subjected to immunoblotting with
antibodies against total and phospho-AKT (Ser473, Thr308). Three individual experiments were performed in triplicate; each lane
indicates a technical replicate. Quantitation graph shown next to immunoblot (white bar = WT, black bar = KLF15-/-). Figure 4
statistical analysis was performed using Student’s t-test for unpaired samples. Values = mean ± SEM. *p<0.05.
doi: 10.1371/journal.pone.0077851.g004
KLF15 and ER Stress
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JNK activation and inflammation are uncoupled from
insulin resistance in KLF15-/- liver
To further explore potential mechanisms underlying the
protection against ER stress-induced insulin resistance in
KLF15-/- liver, we determined whether the absence of KLF15
might inhibit activation of proinflammatory cytokines and/or
JNK. As shown in Figure 5A, mRNA levels of the inflammatory
markers tumor necrosis factor alpha (TNFα) and monocyte
chemoattractant protein-1 (MCP-1) are not decreased, but
increased in KLF15-/- versus WT primary hepatocytes isolated
from chow-fed mice (top) and in liver tissue isolated from HFD-
fed KLF15-/- versus WT mice (bottom), suggesting that
inflammation and insulin resistance are uncoupled in KLF15-/-
liver. We also observe an increase in phosphorylation of both
JNK and AKT protein in KLF15-/- versus WT hepatocytes
(Figure 5B, left) and in KLF15-/- versus WT liver from HFD-fed
mice (Figure 5B, right; AKT result originally shown in Figure
2A). These results are consistent with the uncoupling of JNK
activation from hepatic insulin resistance in KLF15-/- mice. We
conclude that the absence of KLF15 causes increased hepatic
JNK activity and inflammation independent of diet-induced
metabolic effects and that KLF15 may be required for both JNK
and inflammation-mediated insulin resistance in liver.
Role of energy availability in the uncoupling of ER
stress and insulin resistance in KLF15-/- liver
KLF15-/- mice exhibit indicators of elevated FAO, suggesting
an upregulation of catabolism for the purpose of energy
production. This led us to explore the possibility that the
absence of KLF15 creates a low cellular energy state. In
eukaryotic cells, 5’-AMP-activated protein kinase (AMPK) is a
major energy sensing molecule that is activated (via
phosphorylation at threonine 172) in response to a reduction in
the ratio of ATP to AMP (reviewed in 29). Consistent with a
nutrient deprivation phenotype, AMPK phosphorylation is
significantly increased in hepatocytes isolated from chow-fed
KLF15-/- versus WT mice (Figure 5B). An important energy-
sparing function of activated AMPK is to reduce protein
translation by inhibiting mTORC1 [30]. As shown in Figure 5B,
decreased phosphorylation of 70 kD ribosomal protein S6
kinase (p70S6K), a well-characterized target of mTORC1,
provides evidence for reduction of mTORC1 activity in KLF15-/-
hepatocytes. In addition to inhibiting energy-consuming
pathways, phosphorylated AMPK positively regulates the
expression and activity of factors involved in energy production;
e.g., PGC-1α, a major regulator of mitochondrial FAO [31], [32].
Consistent with increased hepatic expression of PGC-1α
mRNA (Figure 1D), we also see an elevation of PGC-1α
protein expression in KLF15-/- versus WT hepatocytes (Figure
5B). A similar pattern of AMPK, mTORC1 and PGC-1α activity
is also found in liver tissue isolated from HFD-fed KLF15-/-
versus WT mice (Figure 5B, right panel). Thus, under both
chow and HFD conditions, KLF15-/- liver exhibits markers of
decreased energy availability.
Interestingly, we find that PGC-1α may play a novel role in
the amelioration of ER stress in the liver. WT primary
hepatocytes were infected with adenovirus containing a lacZ
control vector or a cDNA construct encoding the full-length
open reading frame of PGC-1α. As shown in Figure S3,
Western analysis revealed that overexpression of PGC-1α
suppressed Tm-induced expression of total and
phosphorylated PERK and IRE1α, as well as GRP78 and ATF6
(expression of the PGC-1α target CPT 1a is included as a
positive control). PGC-1α also reduces ATF6 and total/
phospho-PERK expression at baseline, prior to Tm induction of
acute ER stress (vehicle treated). These results identify
PGC-1α as a novel regulator of ER stress signaling in the liver
and suggest that in KLF15-/- liver, PGC-1α induction may occur
as a compensatory response to the absence of KLF15.
Hepatic insulin signaling pathway activity in WT versus
KLF15-/- mice under high-fat feeding conditions
The activation of JNK is known to inhibit insulin signaling
pathway activity upstream of AKT, via serine phosphorylation
of IRS-1 (insulin receptor substrate-1). Thus it is possible that
increased AKT activity in KLF15-/- versus WT liver might result
from an inability of JNK activation to suppress IRS-1 signaling.
To investigate this, liver tissue was isolated from HFD-fed WT
and KLF15-/- mice and assessed for tyrosine (activating)
phosphorylation of both IRS-1 and IRS-2 and for
phosphorylation of IRS-1 at serine 307, as JNK-mediated
phosphorylation of this residue is associated with inhibition of
insulin signaling. As shown in Figure 5C, tyrosine
phosphorylation of IRS-1 and IRS-2 is markedly increased in
KLF15-/- versus WT liver at baseline (saline) and after insulin-
stimulation, despite increased IRS-1 serine 307
phosphorylation. Importantly, levels of IRS-1 and IRS-2 total
protein are also increased in KLF15-/- versus WT liver. These
data indicate that activation of IRS-1 and IRS-2 is increased in
KLF15-/- versus WT liver primarily as a result of increased total
protein levels in KLF15-/- cells, rather than through increased
tyrosine phosphorylation per molecule of IRS-1 or IRS-2.
However, Figure 5C quantitation graphs also indicate a
modest, but statistically significant increase in tyrosine
phosphorylation per molecule of IRS-1 in insulin-stimulated
KLF15-/- versus WT liver, with no significant difference in
tyrosine phosphorylation per molecule of IRS-2 or serine 307
phosphorylation per molecule of IRS-1 between groups. Our
results suggest that in KLF15-/- liver, JNK activity and ER stress
are uncoupled from IRS-1 inhibition. It is possible that the
amount of serine 307 phosphorylation per molecule of IRS-1 in
KLF15-/- liver is not sufficient to reduce activation of IRS-1 to a
level below that of WT liver. Alternatively, phosphorylation of
serine 307 may be necessary, but insufficient to inhibit IRS-1
activation. Furthermore, a recent study indicates that
phosphorylation of IRS-1 at serine 307 can promote insulin
sensitivity, as mice containing an IRS-1 serine 307 to alanine
mutation were more insulin resistant than control mice after
high-fat feeding [33].
Potential mechanisms underlying KLF15 regulation of
mTORC1 activity
mTORC1 has been shown to promote insulin resistance
through mechanisms that include negative feedback inhibition
of AKT [34] and activation of the JNK/IRE pathway, leading to
increased ER stress [35]. Consistent with our finding that
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Figure 5.  Potential mechanisms underlying the uncoupling of ER stress and insulin resistance in KLF15-deficient liver.  A.
Inflammatory marker expression. Total RNA was extracted from hepatocytes isolated from chow-fed 4-month-old male WT and
KLF15-/- mice (top) or from liver tissues isolated from WT and KLF15-/- male mice that received HFD (60% kcal from fat) for 8 weeks
starting at age 2 months, were fasted for 5h, i.p. injected with 10mU/g insulin and sacrificed 10 minutes post-injection (n=3; bottom).
First strand cDNA was subjected to QPCR using primers against TNFα and MCP-1. B. Activation of hepatic JNK, AKT and
markers of energy availability. Western analysis of protein lysates prepared from (left) hepatocytes that were isolated from chow-
fed 3.5-month-old male WT and KLF15-/- mice and harvested 10 minutes after addition of saline or 100nM insulin, or from (right) liver
tissues described in (A). C. Proximal insulin signaling pathway activity. Western analysis of IRS-1 and IRS-2
immunoprecipitated from protein lysates of liver tissues from WT and KLF15-/- male mice that received HFD (60% kcal from fat) for 8
weeks starting at age 2 months, were fasted for 5h, i.p. injected with saline or 10mU/g insulin and sacrificed 10 minutes post-
injection (n=3). D. Effect of KLF15 overexpression on mTORC1 activity. Hepatocytes were isolated from standard chow-fed 2.5-
month-old female WT mice and infected with EV or KLF15-containing adenovirus. Protein lysates were subjected to immunoblotting
with the antibodies shown. E. Effect of KLF15 deficiency on insulin and amino acid-mediated activation of mTORC1.
Hepatocytes were isolated from 3.5 month-old male WT and KLF15-/- mice. Following an overnight incubation in serum-free Williams
E medium (without L-glutamine), cells were harvested after a 45-minute treatment with PBS or (top) 10mM L-glutamine, (middle)
10mM L-leucine or after a 10-minute treatment with PBS or 100nM insulin (bottom). Protein lysates were subjected to
immunoblotting with the antibodies shown. Figure 5 primary hepatocyte experiments were performed twice in triplicate; each lane (in
B, D and E) indicates a technical replicate. For Figure 5 liver blots, each lane represents one mouse. Statistical analysis was
performed using Student’s t-test for unpaired samples. Values = mean ± SEM. *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0077851.g005
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KLF15 deficiency decreases mTORC1 activity, adenoviral
overexpression of KLF15 in WT primary hepatocytes results in
increased phosphorylation of p70S6K, indicating enhanced
mTORC1 activation (Figure 5D). Insulin and amino acids,
particularly glutamine and leucine, are critical activators of
mTORC1 [36], [37]. Because KLF15 is known to regulate
amino acid catabolism [24], we reasoned that KLF15 might be
involved in amino acid regulation of mTORC1 activity. As
shown in Figure 5E, phosphorylation of p70S6K in response to
saturating concentrations (10mM) of either L-glutamine or L-
leucine is decreased in KLF15-/- versus WT hepatocytes. This
suggests that protection against amino acid-mediated
activation of mTORC1 may be one mechanism by which insulin
sensitivity is maintained in KLF15-/- liver. This mechanism may
take on increased significance during high-fat feeding, when
catabolism of branched-chain amino acids, including leucine, is
known to promote insulin resistance in an mTORC1-dependent
manner [38]. Activation of mTORC1 by insulin is also inhibited
in KLF15-/- versus WT hepatocytes (Figure 5E, bottom panel;
results shown are for serum-starved cells. Similar results
(Figure 5B, left panel) for phosphorylation of p70S6K in
response to insulin were achieved in WT and KLF15-/-
hepatocytes grown in complete medium). Further work will
determine whether this inhibition results from a block in amino
acid-mediated activation of mTORC1 in KLF15-/- liver, as prior
studies indicate that amino acids are required for insulin
stimulation of mTORC1 [39].
KLF15 regulation of autophagy
Activation of autophagy is often an indicator of nutrient
starvation [40]. In response to starvation, sugars, fatty acids
and amino acids are made available through autophagic
degradation for the production of ATP. Over the past decade,
numerous autophagy-related genes (ATG-genes) have been
identified that regulate the mammalian autophagic machinery
(reviewed in 41). Here we find that KLF15-/- versus WT
hepatocytes isolated from chow-fed mice show increased
expression of the ATG-genes, ATG3, Beclin (ATG6), ATG7,
ATG12 and microtubule-associated protein 1 light chain 3
(LC3), which are involved in the formation of the double-
membrane vesicle, or autophagosome that surrounds
cytoplasmic contents prior to fusion with the lysosome (Figure
6A, top). It should be mentioned that there are at least 3
mammalian LC3 isoforms (LC3A, LC3B and LC3C), and LC3
proteins are known to be post-translationally modified, resulting
first in LC3-I, which is processed into a faster migrating form,
LC3-II, that associates with the autophagosome membrane
[42]. Thus, decreasing levels of LC3-I and increasing levels of
LC3-II are indicative of autophagosome formation. As shown in
Figure 6A (top), the ratio of LC3A-II to LC3A-I is higher in
KLF15-/- versus WT hepatocytes. We also find increased
expression of autophagic markers in KLF15-/- versus WT liver
isolated from HFD-fed mice (Figure 6A, bottom; LC3A-I was
undetectable in this analysis, although LC3A-II expression
trended upward in KLF15-/- versus WT liver). Using
transmission electron microscopy, we also observe an increase
in the quantity of autophagic vesicles in liver tissue isolated
from KLF15-/- versus WT mice after high-fat feeding (Figure 6B,
bottom). Furthermore, autophagic vesicles were frequently
found in clusters in KLF15-/- hepatocytes, but appeared
scattered in WT hepatocytes (Figure 6B, top). Korolchuk et al.
have recently shown that nutrient deprivation causes
lysosomes to form clusters in the perinuclear region of the cell,
thereby inactivating mTORC1 and promoting autophagosome-
lysosome fusion [43]. Clustering of autophagic vesicles in
KLF15-/- hepatocytes may therefore indicate increased
autophagic flux and also suggest a potential mechanism for low
energy state-mediated reduction of mTORC1 activity in the
absence of KLF15.
While increased autophagic vesicle numbers and expression
of ATG-genes generally indicate enhanced autophagic activity,
the possibility still exists that our data reflect a block in
lysosomal degradation, rather than accelerated formation of
autophagosomes. To assess this, we treated WT and KLF15-/-
hepatocytes with chloroquine (CQ), an agent that blocks the
activity of lysosomal hydrolases and reduces autophagosome-
lysosome fusion. As shown in Figure 6C, the rise in LC3B-II
content in CQ-treated versus untreated KLF15-/- hepatocytes is
higher than that in WT hepatocytes. This suggests an increase
in autophagic flux and also that the slight decrease in LC3B-II
content in untreated KLF15-/- versus WT hepatocytes may
indicate a more rapid turnover of autophagosomes. These
results provide additional evidence that KLF15-/- mice maintain
a low energy state compared to WT controls, even under high-
nutritional conditions. In addition, the maintenance of increased
autophagic flux may be a mechanism by which KLF15-/- mice
are protected against high-fat diet-induced insulin resistance.
Finally, Figure 7 shows a proposed model of the mechanisms
involved in KLF15 regulation of ER stress-mediated insulin
resistance based upon our current findings.
Discussion
A key finding in this study is that KLF15 deficiency results in
the uncoupling of hepatic ER stress and insulin resistance.
Increased UPR activity in KLF15-/- versus WT liver and primary
hepatocytes as well as ultrastructural examination of the ER
provide evidence that the absence of KLF15 results in chronic
ER stress. However, KLF15-/- mice are protected against ER
stress-induced hepatic insulin resistance and steatosis
compared to WT controls. Our data highlight the importance of
mTORC1 signaling in ER stress-mediated insulin resistance.
ER stress plays an important role as an upstream activator of
mTORC1 [35], [44]. In addition, a number of studies show that
increased mTORC1 activity promotes ER stress and insulin
resistance and that inhibition of mTORC1 ameliorates both of
these conditions ([44], [45] [46],). In KLF15-/- versus WT liver,
mTORC1 activity and insulin resistance are decreased, yet this
is not associated with a reduction in ER stress. This raises the
possibility that hepatic insulin resistance does not occur in
response to ER stress per se, but rather as a result of
cooperation between the UPR and mTORC1 signaling
pathways. Our data suggest that the ability of KLF15-/- mice to
maintain a low energy state, particularly under high-fat feeding
conditions, prevents the upregulation of mTORC1 activity and
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inhibition of autophagy that, in concert with ER stress signaling,
lead to hepatic insulin resistance.
ER stress has been implicated in the development of hepatic
steatosis [47], and reduction of ER stress in rodents has been
shown to decrease hepatic lipid content (reviewed in 48). In the
current study, we have found that KLF15-/- mice are protected
against HFD and ER stress-mediated steatosis and it is likely
that increased AMPK activity in KLF15-/- liver contributes to this
Figure 6.  KLF15 regulation of autophagy.  A. Autophagy marker expression in WT and KLF15-/- primary hepatocytes and
liver tissue. (Top) Hepatocytes were isolated from standard chow-fed 4-month-old male WT and KLF15-/- mice. Protein lysates
were subjected to immunoblotting with the antibodies shown. (Bottom) 2-month-old WT and KLF15-/- male mice were placed on a
HFD (60% kcal from fat) for 8 weeks. Mice were fasted for 5h, then i.p. injected with 10mU/g insulin and sacrificed 10 minutes post-
injection. Lysates from flash frozen livers were subjected to immunoblotting with the antibodies shown (n=3). Quantitation graphs
are shown next to immunoblots (white bar = WT, black bar = KLF15-/-). B. Ultrastructural examination of autophagic vesicles in
liver tissue from HFD-fed WT and KLF15-/- mice. WT and KLF15-/- female mice (n=3) received HFD (60% kcal from fat) for 4
weeks starting at age 3 months. Mice were fasted for 21h before sacrifice and liver tissue was removed and prepared for
transmission electron microscopy (TEM) analysis as described in Materials and Methods. (Top) Electron micrographs (original
magnification = 43,000x) of liver sections showing clustering of autophagic vesicles (indicated by red arrows) in KLF15-/- versus WT
hepatocytes. Scale bar = 200nm. (Bottom) Quantitation of autophagic vesicles in WT and KLF15-/- liver. TEM was used to visualize
autophagic vesicles in intact hepatocytes. Values = number of autophagic vesicles per cell calculated from 15 hepatocytes per
group. C. Chloroquine treatment of primary hepatocytes. Hepatocytes were isolated from 3.5-month old male WT and KLF15-/-
mice and treated with vehicle or 50µM chloroquine (CQ) for 2h prior to harvest. Protein lysates were subjected to immunoblotting
with an antibody against LC3B. Figure 6 primary hepatocyte experiments were performed at least twice in triplicate; each lane
indicates a technical replicate. For Figure 6A liver blot, each lane represents one mouse. Statistical analysis was performed using
Student’s t-test for unpaired samples. Values = mean ± SEM. *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0077851.g006
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phenotype through inhibition of mTORC1 activity and induction
of PGC-1α expression. mTORC1 plays an important role in
promoting hepatic steatosis through its control of SREBP, a
master regulator of lipogenesis, and inhibition of mTORC1
protects against HFD-induced hepatic lipid accumulation [49],
[50]. Increased PGC1α expression in KLF15-/- liver may also
play a causal role in protection against steatosis through
enhancement of mitochondrial FAO. Indeed, studies in ATF6-
knockout mice show that increased hepatic lipid accumulation
caused by ER stress can result from blockage of β-oxidation of
fatty acids [51]. In addition to observing increased hepatic
expression of PGC-1α in KLF15-/- mice, we also find that
Figure 7.  Proposed model for KLF15 regulation of ER stress-mediated insulin resistance.  The diagram places KLF15 into
the network of ER stress, mTORC1 and autophagy signaling pathways that regulate the onset of insulin resistance (red lines
indicate pathways that are activated with KLF15 deficiency; dotted lines represent negative feedback inhibition). Our data indicate
that acute ER stress induces KLF15 and that KLF15 activates mTORC1. Previous studies have shown that ER stress can induce
mTORC1, although the mechanisms by which this occurs have not been fully delineated. Activation of mTORC1 leads to inhibition
of autophagy as well as feedback inhibition of AKT. Because KLF15 overexpression reduces UPR signaling, it is hypothesized that
1) induction of KLF15 in response to ER stress may serve to reduce ER stress levels through negative feedback inhibition and 2) as
ER stress is resolved, KLF15 would no longer be induced and mTORC1 activity would decrease, allowing for increased signaling
through AKT. The absence of KLF15 results in ER stress and inflammation, but also activation of AMPK and reduced mTORC1
activity, preventing mTORC1 pathway-mediated inhibition of AKT. Loss of KLF15 also leads to elevated PGC-1α expression,
potentially resulting in increased fatty acid oxidation (FAO), which may indirectly promote insulin sensitivity by reducing hepatic lipid
content.
doi: 10.1371/journal.pone.0077851.g007
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PGC-1α suppresses ER stress induction of UPR activity in WT
primary hepatocytes. In contrast, PGC-1α recently has been
shown to cooperate with ATF6 to induce UPR genes in skeletal
muscle in response to exercise [52]. This tissue-specific
regulation of the UPR by PGC-1α is not unexpected, given the
different roles of UPR signaling in liver versus skeletal muscle.
mTORC1 activity depends largely upon signals emanating
from energy levels, insulin and amino acids. Insulin stimulation
of mTORC1 activity is known to occur through the PI3K/AKT
pathway. Phosphorylation of the GTPase-activating protein,
tuberous sclerosis complex 2 (TSC2), by AKT prevents TSC2
from inhibiting the small GTPase Rheb, an activator of
mTORC1 (reviewed in 53). Insulin is also thought to activate
mTORC1 via AKT-mediated phosphorylation of an inhibitory
binding partner of mTOR termed proline-rich Akt/PKB substrate
40 kDa, or PRAS40 [54]. Amino acids appear to use a
distinct pathway for the activation of mTORC1 that is mediated
by the Rag family of small GTPases [55]. Recent evidence
shows that amino acids stimulate Rag GTPase-mediated
translocation of mTORC1 to lysosomes, where mTORC1 is
then activated by Rheb [56]. These data may explain previous
studies indicating that amino acids are required for activation of
mTORC1 by insulin [39]. Here we find that activation of
mTORC1 is markedly inhibited in KLF15-/- versus WT
hepatocytes in response to insulin and to the critical regulatory
amino acids, leucine and glutamine. Although the underlying
mechanism is yet to be defined, the previous identification of
KLF15 as a regulator of amino acid catabolism [24] suggests
the possibility that KLF15 is a specific effector of amino acid-
mediated mTORC1 activation; inhibition of insulin-mediated
mTORC1 activation in KLF15-/- hepatocytes would then occur
as a secondary effect. In addition, consistent with impaired
amino acid utilization, KLF15-/- mice are unable to maintain
nitrogen homeostasis, exhibiting hyperammonemia and
defective ureagenesis [26]. Thus, given the sensitivity of
mTORC1 to the availability of nitrogen sources [57], the
inability of KLF15-/- mice to appropriately metabolize nitrogen
may contribute to the inhibition of mTORC1 in response to
amino acids.
While the mechanism behind the maintenance of a low
energy state in KLF15-/- mice has not been resolved, we
reasoned that it results from either an inability to generate
sufficient ATP or from increased energy expenditure
(consumption), or a combination of both. Figure 1B shows that
high-fat feeding reduces energy expenditure in both WT and
KLF15-/- mice, but to a greater extent in WT mice. We attribute
this to the fact that WT mice gain significantly more fat mass
than KLF15-/- mice in response to a HFD. Importantly, we know
that under chow conditions, while energy expenditure is not
significantly different between groups, KLF15-/- mice already
show indications of a nutrient starvation phenotype, as
evidenced by increased PGC-1α expression and
phosphorylation of AMPK, decreased mTORC1 activity and
activation of autophagy. This suggests that the inability of
KLF15-/- mice to generate ATP, rather than increased energy
expenditure, is responsible for their low energy state. Our
previous work shows that KLF15-/- mice utilize amino acids less
efficiently than WT mice, resulting in limited substrate for
gluconeogenesis [24]. Thus, defective amino acid catabolism is
likely to play an important role in keeping the AMP/ATP ratio
high in KLF15-/- liver, causing activation of AMPK.
Defective amino acid catabolism may be promoting ER
stress in KLF15-/- mice through several mechanisms. First,
circulating levels of several amino acids are increased in
KLF15-/- mice [24]. This amino acid surplus could potentially
contribute to a chronic increase in protein translation that, over
time, may result in accumulation of misfolded proteins and ER
dysfunction. Also, inefficient use of amino acids for ATP
production may cause KLF15-/- mice to increase their use of
glucose as an alternative energy source. Indeed, KLF15-/- mice
exhibit decreased plasma glucose levels in the fed state and
hypoglycemia after an overnight fast [24]. This could contribute
to ER stress by causing glycosylation defects that lead to
protein misfolding.
Finally, the process of autophagy has been the focus of
much attention recently for its role in the regulation of a variety
of physiological and pathological states, including cancer,
neurodegenerative disorders, aging and heart disease. It will
be important to further investigate the mechanisms by which
KLF15 controls autophagy in the liver and in other tissues. In
conclusion, this work identifies KLF15 as a critical regulator of
ER stress, mTORC1 and autophagy signaling in the liver and
underscores the importance of this factor in the maintenance of
energy balance and glucose homeostasis.
Materials and Methods
Animals
Mouse studies were approved by the Institutional Animal
Care and Use Committee at the University of Massachusetts
Medical School (Permit Number: A-2065), and all efforts were
made to minimize discomfort. KLF15-/- mice backcrossed onto
a C57BL/6 background were generated and genotyped as
previously described [58]. Mice were housed under pathogen-
free conditions and maintained on a 12-hour light-dark cycle
with free access to standard chow (ProLab Isopro RMH 3000,
LabDiet) and water. High-fat fed mice received a diet
containing 60% kcal from fat (Research Diets #D12492).
Reagents
A cDNA containing the full-length open reading frame of
KLF15 (pcDNA3.1-KLF15 FLAG) was subcloned into an
expression vector as previously described [58]. Empty vector
(EV) control and pcDNA3.1-KLF15 FLAG adenoviral vectors
were prepared by Applied Viromics, LLC (Fremont, CA). The
PGC-1α and control lacZ adenoviral vectors were kindly
provided by the laboratory of Dr. Bruce Spiegelman. The
shControl and shKLF15 adenoviral vectors were a gift from the
laboratory of Dr. Mukesh Jain.
Hyperinsulinemic-euglycemic clamps
A 2 hour hyperinsulinemic-euglycemic clamp was conducted
with a primed (150 mU/kg body weight) infusion of human
insulin followed by a continuous infusion of insulin at a rate of
2.5 mU/kg/min to raise and maintain plasma insulin within a
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physiological range (~300 pM). Blood samples (20 μl) were
collected at 10-20 min intervals for the immediate
measurement of plasma glucose concentration, and 20%
glucose was infused at variable rates to maintain glucose at
basal concentrations (~6mM). Insulin-stimulated whole body
glucose metabolism was assessed with a continuous infusion
of [3-3H]glucose (0.1 mCi/min) throughout the clamp. Clamp
hepatic glucose production was calculated as the difference
between whole body glucose turnover and glucose infusion
rate during the insulin clamp.
Body composition analysis and metabolic cages
Measurement of food intake, VO2 consumption, VCO2
production and physical activity over a 3-day period was
performed using metabolic cages (TSE Systems, Bad
Homburg, Germany). Whole-body fat mass was noninvasively
measured in conscious mice using 1H-MRS (Echo Medical
Systems, Houston, TX).
Immunoblotting
Flash-frozen tissues were ground in liquid nitrogen and
sonicated in lysis buffer containing 50mM HEPES pH 7.4,
100mM sodium pyrophosphate, 10mM EDTA, 100mM sodium
fluoride, 10mM sodium orthovanadate, 2mM PMSF and 1%
Triton X-100. Protease inhibitor cocktail (SIGMA P2714) and
phosphatase inhibitor cocktails 2 and 3 (SIGMA P5726, P0044)
were added as recommended by the manufacturer.
Hepatocytes were harvested in NP40 Cell Lysis Buffer
(Invitrogen FNN0021) supplemented with 1mM PMSF and
protease inhibitor cocktail (SIGMA P2714), phosphatase
inhibitor cocktails 2 and 3 (SIGMA P5726, P0044) as
recommended by the manufacturer. Lysates were rotated at
4°C for 1 hour, centrifuged at 18,000 x g for 2 minutes and
supernatant was assayed for protein content using a kit from
Pierce (Thermo Scientific #23227). Proteins were resolved by
SDS-PAGE and transferred to nitrocellulose membranes
(Hybond ECL, RPN2020D). Immunoblotting was performed
using antibodies against AKT, p-AKT(Ser 473), p-AKT(Thr308),
PERK, p-PERK (Thr980), eIF2α, p-eIF2α (Ser51), IRE1α and
GRP78 (BiP), p70 S6 Kinase, 4E-BP1, p-4E-BP1(Ser65),
AMPK, p-AMPK (Thr172), ATG3, Beclin, ATG7, ATG12, LC3A,
LC3B, β-actin and α-Tubulin (Cell Signaling Technology),
ATF6, GAPDH and ALT1(GPT) (Santa Cruz Biotechnology), p-
JNK (Thr183/Tyr185, Thr221/Tyr223), p-p70 S6 Kinase
(Thr389) and PGC-1 (Millipore), CPT 1a and KLF15
(ProteinTech Group, Inc.), p-IRE1α (Novus Biologicals) and
SAPK/JNK (Calbiochem). Anti-rabbit or mouse IgG, HRP-
linked secondary antibodies were purchased from Cell
Signaling Technology. Immunoreactive band intensity was
quantified on the FluorChem HD2 System using AlphaEase
densitometry software (Alpha Innotech, San Leandro, CA).
Immunoprecipitation of IRS-1/IRS-2
Liver lysates were diluted to 2µg/ul protein in 500µl of tissue
lysis buffer. Lysates were precleared by adding 25µl of protein
A/G agarose (Pierce #20421) and 3µl normal rabbit IgG (Santa
Cruz Biotechnology) followed by 1h rotation at 4C. Samples
were centrifuged at 10K RPM for 1 min at 4C to pellet agarose
beads, and supernatant was transferred to new tubes. 2µg of
IRS-1 or IRS-2 antibody (gifts from laboratory of Leslie Shaw)
and 25µl of protein A/G agarose were added to supernatant,
followed by O/N rotation at 4C. Beads were pelleted and
washed 3x in 400µl tissue lysis buffer. After final wash, lysis
buffer was removed and 25µl of 2x sample buffer was added to
bead pellet. Samples were boiled for 5 min and subjected to
gel electrophoresis. Proteins resolved by SDS-PAGE were
transferred to a nitrocellulose membrane and immunoblotting
was performed using antibodies against total IRS-1,
phosphorylated tyrosine (PY99) (Santa Cruz Biotechnology)
and phosphorylated IRS-1(Ser307), total IRS-2 (Cell
Signaling).
Real-Time Quantitative PCR (qPCR)
Mouse gene-specific primers were selected from the
PrimerBank database [59] or were user-designed (sequences
listed in Table S1). Total RNA was isolated from cells or tissues
using TRIzol Reagent (Life Technologies) according to
manufacturer’s instructions and reverse transcribed using an
iScript Advanced cDNA Synthesis Kit (BioRad). An iQ SYBR
Green Supermix Kit (BioRad) was used for cDNA amplification
with a CFX96 Real-Time PCR Detection System (BioRad).
Expression values were normalized against hypoxanthine
guanine phosphoribosyl transferase (HPRT) and beta-2
microglobulin (B2m), (Figure 1D); HPRT and TATA-box binding
protein (TBP), (Figures 2D, 5A) or HPRT (Figure 3C).
Electron microscopy
Transmission electron microscopy was performed using
tissue washed with 0.1 M sodium cacodylate buffer (pH 7.2),
and fixed with 2.5% gluteraldehyde in the same buffer, for 30
min at room temperature and in the same fresh fixative
overnight at 4°C. The tissue was then rinsed for 10 min in 0.1
M sodium cacodylate buffer (pH 7.2) 3 times and post-fixed
(1h) in 1% (wt/vol) osmium tetroxide in distilled water. The fixed
tissue was rinsed in double-distilled water and dehydrated
through a graded ethanol series before two changes of 100%
ethanol. Samples were then infiltrated with 2 changes of 100%
propylene oxide and then with a 50%/50% propylene oxide /
SPI-Pon 812 resin mixture. The following day, 3 changes of
fresh 100% SPI-Pon 812 resin were done before the samples
were polymerized at 68°C in flat embedding molds. The epoxy
blocks were cut and mounted on blank epoxy stubs with a drop
of Super Glue, and ultrathin sections were cut on a Reichart-
Jung ultramicrotome using a diamond knife. The sections were
collected and mounted on copper support grids, contrasted
with lead citrate and uranyl acetate, and examined using an
FEI Tecnai 12 BT with 80Kv accelerating voltage. Images were
captured using a Gatan TEM CCD camera. ER lumen
diameters were measured using Gatan DigitalMicrograph
Software.
Metabolic measurements
Blood glucose values were measured using a One Touch
Ultra glucometer and test strips (Lifescan). For GTT, mice were
fasted overnight and received an intraperitoneal injection of 1g
glucose/kg body weight. Tail vein blood samples were
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assessed for glucose concentration immediately before
injection (Time 0) and at 15, 30, 60 and 120 minutes post-
injection. Plasma insulin concentration was determined using
an Ultrasensitive Mouse Insulin ELISA Kit (Crystal Chem, Inc.).
A Triglyceride Quantification Kit (MBL International) was used
to measure lipid content in frozen liver samples.
Histological analysis
Frozen liver tissues were sectioned and treated with
hematoxylin nuclear stain and Oil Red O for detection of lipid at
the Morphology Core Facility at UMass Medical School.
Cell culture
The AML12 (alpha mouse liver 12) hepatocyte cell line was
purchased from the American Type Culture Collection and
grown in a 1:1 mixture of Dulbecco's modified Eagle's medium
and Ham's F12 medium (Mediatech #10-090-CV) with 10%
FBS, 100U/ml penicillin, 100µg/ml streptomycin, 1X Insulin-
Transferrin-Selenium (ITS) supplement (Mediatech #25-800-
CR) and 40 ng/ml dexamethasone. Cells were plated at 5 x 105
cells per well in 6-well plates one day prior to treatment with
Tm or Tg. Primary hepatocytes were isolated via liver perfusion
(see Protocol S1). Cells were plated at 1 x 106 cells per well in
6-well collagen-coated plates and grown in William’s Medium E
(Life Technologies, #12551032) supplemented with 10% FBS,
100U/ml penicillin, 100µg/ml streptomycin, 1nM insulin,
40ng/ml dexamethasone and 5µg/ml transferrin.
Statistical Analysis
Values are expressed as means ± SEM. Comparisons
between groups were made using a two-tailed Student’s t test
for unpaired samples or a repeated measures ANOVA with a
Bonferroni post hoc test where appropriate. Differences were
considered statistically significant at p < 0.05.
Supporting Information
Figure S1.  Glucose tolerance test. WT and KLF15-/- (KO)
male mice were placed on a high-fat diet (HFD; 60% kcal from
fat) at 3-4 months of age. After 8 weeks of HFD, mice were
fasted for 16h and received an intraperitoneal injection of 1g
glucose/kg body weight. Tail vein blood samples were
assessed for glucose concentration immediately before
injection (Time 0) and at 15, 30, 60 and 120 minutes post-
injection (n=6-7). Left: blood glucose concentrations during the
GTT. Middle: area under the curve calculations for glucose
values. Right: plasma insulin concentrations during the GTT.
Plasma isolated from tail vein blood samples collected at Time
0 and at 15, 30 and 60 minutes after glucose injection was
assayed for insulin concentration using an ELISA kit. Statistical
comparisons were made using Student’s t test for unpaired
samples (AUC) or analysis of variance for repeated measures
with a Bonferroni post hoc test (GTT/Insulin during GTT).
Values = mean ± SEM; **p<0.01 compared to WT control.
(TIF)
Figure S2.  Plasma ketone measurements. Male WT and
KLF15-/- (KO) mice were placed on a high-fat diet (HFD; 60%
kcal from fat) at 3-4 months of age. 3-hydroxybutyrate levels
were measured in whole blood from overnight-fasted and ad
libitum fed mice, 9 and 10 weeks, respectively, after the start of
HFD using a MediSense Precision Xtra Monitor with β-Ketone
Test Strips (Abbott Laboratories). n=6. Statistical comparisons
were made using Student’s t test for unpaired samples. Values
= mean ± SEM; **p<0.01 compared to WT control.
(TIF)
Figure S3.  Adenoviral overexpression of PGC-1α in
primary hepatocytes. Primary hepatocytes isolated from 3.5-
month-old chow-fed WT male mice were infected with
adenovirus containing PGC-1α or lacZ control. Cells were
harvested after 20h treatment with vehicle (DMSO) or 2µg/ml
Tm. Protein lysates were subjected to immunoblotting with the
antibodies shown. A quantitation graph is shown below the
blot: protein expression levels were normalized against β-actin,
α-tubulin or GAPDH. Statistical analysis was performed using
Student’s t-test for unpaired samples. Values = mean ± SEM of
triplicate values, representative of two individual experiments.
*p<0.05; **p<0.01. # = p<0.07; Statistical comparisons refer to
PGC-1α vehicle versus lacZ vehicle or to PGC-1α-Tm versus
lacZ-Tm.
(TIF)
Protocol S1.  Description of procedure for liver perfusion
and primary hepatocyte isolation in mice.
(DOC)
Table S1.  QPCR Primer List, Related to Figures 1D, 2D, 3C
and 5A.
(DOC)
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